Literature DB >> 26199040

Central cholinergic dysfunction could be associated with oropharyngeal dysphagia in early Parkinson's disease.

Kyung Duck Lee1, Jung Hoi Koo1, Sun Hong Song1, Kwang Deog Jo2, Moon Kyu Lee2, Wooyoung Jang3,4.   

Abstract

Dysphagia is an important issue in the prognosis of Parkinson's disease (PD). Although several studies have reported that oropharyngeal dysphagia may be associated with cognitive dysfunction, the exact relationship between cortical function and swallowing function in PD patients is unclear. Therefore, we investigated the association between an electrophysiological marker of central cholinergic function, which reflected cognitive function, and swallowing function, as measured by videofluoroscopic studies (VFSS). We enrolled 29 early PD patients. Using the Swallowing Disturbance Questionnaire (SDQ), we divided the enrolled patients into two groups: PD with dysphagia and PD without dysphagia. The videofluoroscopic dysphagia scale (VDS) was applied to explore the nature of the dysphagia. To assess central cholinergic dysfunction, short latency afferent inhibition (SAI) was evaluated. We analyzed the relationship between central cholinergic dysfunction and oropharyngeal dysphagia and investigated the characteristics of the dysphagia. The SAI values were significantly different between the two groups. The comparison of each VFSS component between the PD with dysphagia group and the PD without dysphagia group showed statistical significance for most of the oral phase components and for a single pharyngeal phase component. The total score on the VDS was higher in the PD with dysphagia group than in the PD without dysphagia group. The Mini-Mental State Examination and SAI values showed significant correlations with the total score of the oral phase components. According to binary logistic regression analysis, SAI value independently contributed to the presence of dysphagia in PD patients. Our findings suggest that cholinergic dysfunction is associated with dysphagia in early PD and that an abnormal SAI value is a good biomarker for predicting the risk of dysphagia in PD patients.

Entities:  

Keywords:  Dysphagia; Electrophysiology; Parkinson’s disease; Short latency afferent inhibition; VFSS

Mesh:

Year:  2015        PMID: 26199040     DOI: 10.1007/s00702-015-1427-z

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  45 in total

Review 1.  Prevalence of oropharyngeal dysphagia in Parkinson's disease: a meta-analysis.

Authors:  J G Kalf; B J M de Swart; B R Bloem; M Munneke
Journal:  Parkinsonism Relat Disord       Date:  2011-12-03       Impact factor: 4.891

2.  Effects of lorazepam on short latency afferent inhibition and short latency intracortical inhibition in humans.

Authors:  V Di Lazzaro; A Oliviero; E Saturno; M Dileone; F Pilato; R Nardone; F Ranieri; G Musumeci; T Fiorilla; P Tonali
Journal:  J Physiol       Date:  2005-02-17       Impact factor: 5.182

3.  Evidence for adaptive cortical changes in swallowing in Parkinson's disease.

Authors:  Sonja Suntrup; Inga Teismann; Joke Bejer; Inga Suttrup; Martin Winkels; David Mehler; Christo Pantev; Rainer Dziewas; Tobias Warnecke
Journal:  Brain       Date:  2013-02-14       Impact factor: 13.501

4.  Short latency afferent inhibition in Parkinson's disease patients with dementia.

Authors:  Ozlem Celebi; Cağrı Mesut Temuçin; Bulent Elibol; Esen Saka
Journal:  Mov Disord       Date:  2012-05-17       Impact factor: 10.338

5.  Response of parkinsonian swallowing dysfunction to dopaminergic stimulation.

Authors:  P C Hunter; J Crameri; S Austin; M C Woodward; A J Hughes
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-11       Impact factor: 10.154

6.  Swallowing abnormalities and dyskinesia in Parkinson's disease.

Authors:  Francisca Sueli Monte; Francisco Pereira da Silva-Júnior; Pedro Braga-Neto; Miguel Angelo Nobre e Souza; Veralice Meireles Sales de Bruin
Journal:  Mov Disord       Date:  2005-04       Impact factor: 10.338

7.  Speech and Swallowing in Parkinson's Disease.

Authors:  Kris Tjaden
Journal:  Top Geriatr Rehabil       Date:  2008

8.  Videofluorographic observations on swallowing in patients with dysphagia due to neurodegenerative diseases.

Authors:  Masahiro Nagaya; Teruhiko Kachi; Takako Yamada; Yasunori Sumi
Journal:  Nagoya J Med Sci       Date:  2004-05       Impact factor: 1.131

9.  Swallowing disorders in Parkinson's disease.

Authors:  Anna Potulska; Andrzej Friedman; Leszek Królicki; Andrzej Spychala
Journal:  Parkinsonism Relat Disord       Date:  2003-08       Impact factor: 4.891

Review 10.  Dysautonomia rating scales in Parkinson's disease: sialorrhea, dysphagia, and constipation--critique and recommendations by movement disorders task force on rating scales for Parkinson's disease.

Authors:  Marian L Evatt; K Ray Chaudhuri; Kelvin L Chou; Ester Cubo; Vanessa Hinson; Katie Kompoliti; Chengwu Yang; Werner Poewe; Olivier Rascol; Cristina Sampaio; Glenn T Stebbins; Christopher G Goetz
Journal:  Mov Disord       Date:  2009-04-15       Impact factor: 10.338

View more
  9 in total

Review 1.  PET/MRI of central nervous system: current status and future perspective.

Authors:  Zhen Lu Yang; Long Jiang Zhang
Journal:  Eur Radiol       Date:  2016-01-15       Impact factor: 5.315

Review 2.  Gut dysfunction in Parkinson's disease.

Authors:  Adreesh Mukherjee; Atanu Biswas; Shyamal Kumar Das
Journal:  World J Gastroenterol       Date:  2016-07-07       Impact factor: 5.742

Review 3.  Cortical afferent inhibition abnormalities reveal cholinergic dysfunction in Parkinson's disease: a reappraisal.

Authors:  Raffaele Nardone; Francesco Brigo; Viviana Versace; Yvonne Höller; Frediano Tezzon; Leopold Saltuari; Eugen Trinka; Luca Sebastianelli
Journal:  J Neural Transm (Vienna)       Date:  2017-08-12       Impact factor: 3.575

Review 4.  Evolving concepts on bradykinesia.

Authors:  Matteo Bologna; Giulia Paparella; Alfonso Fasano; Mark Hallett; Alfredo Berardelli
Journal:  Brain       Date:  2020-03-01       Impact factor: 13.501

5.  Constipation, deficit in colon contractions and alpha-synuclein inclusions within the colon precede motor abnormalities and neurodegeneration in the central nervous system in a mouse model of alpha-synucleinopathy.

Authors:  Lucia Rota; Carolina Pellegrini; Laura Benvenuti; Luca Antonioli; Matteo Fornai; Corrado Blandizzi; Antonino Cattaneo; Emanuela Colla
Journal:  Transl Neurodegener       Date:  2019-02-06       Impact factor: 8.014

Review 6.  A multinational consensus on dysphagia in Parkinson's disease: screening, diagnosis and prognostic value.

Authors:  Giuseppe Cosentino; Micol Avenali; Antonio Schindler; Nicole Pizzorni; Cristina Montomoli; Giovanni Abbruzzese; Angelo Antonini; Filippo Barbiera; Marco Benazzo; Eduardo Elias Benarroch; Giulia Bertino; Emanuele Cereda; Pere Clavè; Pietro Cortelli; Roberto Eleopra; Chiara Ferrari; Shaheen Hamdy; Maggie-Lee Huckabee; Leonardo Lopiano; Rosario Marchese Ragona; Stefano Masiero; Emilia Michou; Antonio Occhini; Claudio Pacchetti; Ronald F Pfeiffer; Domenico A Restivo; Mariangela Rondanelli; Giovanni Ruoppolo; Giorgio Sandrini; Anthony H V Schapira; Fabrizio Stocchi; Eduardo Tolosa; Francesca Valentino; Mauro Zamboni; Roberta Zangaglia; Mario Zappia; Cristina Tassorelli; Enrico Alfonsi
Journal:  J Neurol       Date:  2021-08-21       Impact factor: 4.849

Review 7.  Gastrointestinal Dysfunction in Parkinson's Disease: Current and Potential Therapeutics.

Authors:  Myat Noe Han; David I Finkelstein; Rachel M McQuade; Shanti Diwakarla
Journal:  J Pers Med       Date:  2022-01-21

8.  Anodal Transcranial Direct Current Stimulation Could Modulate Cortical Excitability and the Central Cholinergic System in Akinetic Rigid-Type Parkinson's Disease: Pilot Study.

Authors:  Eungseok Oh; Jinse Park; Jinyoung Youn; Wooyoung Jang
Journal:  Front Neurol       Date:  2022-03-24       Impact factor: 4.003

Review 9.  A Review on Tramiprosate (Homotaurine) in Alzheimer's Disease and Other Neurocognitive Disorders.

Authors:  Sagrario Manzano; Luis Agüera; Miquel Aguilar; Javier Olazarán
Journal:  Front Neurol       Date:  2020-07-07       Impact factor: 4.003

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.